Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Daly

Showing results (261-270 of 286) with videos related to

Pageof 29
Sort By:
Endocrine|November 27, 2015
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndromeLuciana A Naves, Adrian F Daly, Luiz Augusto Dias, et al.
European Journal of Endocrinology|January 20, 2017
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analoguesS E Franck, T I M Korevaar, P Petrossians, et al.
Endocrine-Related Cancer|August 14, 2013
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutationsMarie-Lise Jaffrain-Rea, Sandra Rotondi, Annarita Turchi, et al.
Journal of Molecular Endocrinology|June 11, 2016
Characterization of GPR101 transcript structure and expression patternsGiampaolo Trivellin, Ivana Bjelobaba, Adrian F Daly, et al.
Clinical Genetics|May 29, 2010
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromesC A Stratakis, M A Tichomirowa, S Boikos, et al.
Cancer & Metabolism|February 22, 2022
Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomicsAnni M Y Zhang, Ken H Chu, Brian F Daly, et al.
Endocrine-Related Cancer|June 27, 2009
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implicationsMarie-Lise Jaffrain-Rea, Mariolina Angelini, Donatella Gargano, et al.
The Journal of Clinical Endocrinology and Metabolism|June 27, 2020
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in AcromegalyEva C Coopmans, Tim I M Korevaar, Sebastiaan W F van Meyel, et al.
Endocrine-Related Cancer|January 4, 2015
Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequencesIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Genome Medicine|September 13, 2024
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locusAdrian F Daly, Leslie A Dunnington, David F Rodriguez-Buritica, et al.
Pageof 29

Showing results (261-270 of 286) with videos related to

Sort By:
Pageof 29
Endocrine|November 27, 2015
Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndromeLuciana A Naves, Adrian F Daly, Luiz Augusto Dias, et al.
European Journal of Endocrinology|January 20, 2017
A multivariable prediction model for pegvisomant dosing: monotherapy and in combination with long-acting somatostatin analoguesS E Franck, T I M Korevaar, P Petrossians, et al.
Endocrine-Related Cancer|August 14, 2013
Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutationsMarie-Lise Jaffrain-Rea, Sandra Rotondi, Annarita Turchi, et al.
Journal of Molecular Endocrinology|June 11, 2016
Characterization of GPR101 transcript structure and expression patternsGiampaolo Trivellin, Ivana Bjelobaba, Adrian F Daly, et al.
Clinical Genetics|May 29, 2010
The role of germline AIP, MEN1, PRKAR1A, CDKN1B and CDKN2C mutations in causing pituitary adenomas in a large cohort of children, adolescents, and patients with genetic syndromesC A Stratakis, M A Tichomirowa, S Boikos, et al.
Cancer & Metabolism|February 22, 2022
Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomicsAnni M Y Zhang, Ken H Chu, Brian F Daly, et al.
Endocrine-Related Cancer|June 27, 2009
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implicationsMarie-Lise Jaffrain-Rea, Mariolina Angelini, Donatella Gargano, et al.
The Journal of Clinical Endocrinology and Metabolism|June 27, 2020
Multivariable Prediction Model for Biochemical Response to First-Generation Somatostatin Receptor Ligands in AcromegalyEva C Coopmans, Tim I M Korevaar, Sebastiaan W F van Meyel, et al.
Endocrine-Related Cancer|January 4, 2015
Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequencesIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Genome Medicine|September 13, 2024
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locusAdrian F Daly, Leslie A Dunnington, David F Rodriguez-Buritica, et al.
Pageof 29